title: Response to comments on 'Cytogenetic effects in children treated with methylphenidate' by El-Zein et al.
authors.forename: Randa A
authors.initials: RA
authors.lastname: El-Zein
authors.forename: Matthew J
authors.initials: MJ
authors.lastname: Hay
authors.forename: Mirtha S
authors.initials: MS
authors.lastname: Lopez
authors.forename: Melissa L
authors.initials: ML
authors.lastname: Bondy
authors.forename: Debra L
authors.initials: DL
authors.lastname: Morris
authors.forename: Marvin S
authors.initials: MS
authors.lastname: Legator
authors.forename: Sherif Z
authors.initials: SZ
authors.lastname: Abdel-Rahman
mesh_terms: D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy; D002273:Carcinogens; D000697:Central Nervous System Stimulants / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D002869:Chromosome Aberrations / Q000139:chemically induced*; D004249:DNA Damage; D023381:Endpoint Determination; D006801:Humans; D008774:Methylphenidate / Q000009:adverse effects* / Q000627:therapeutic use; D009152:Mutagenicity Tests; D009153:Mutagens; D009369:Neoplasms / Q000139:chemically induced; D015203:Reproducibility of Results; D012107:Research Design; D012307:Risk Factors
chemical_list: D002273:Carcinogens; D000697:Central Nervous System Stimulants; D009153:Mutagens; D008774:Methylphenidate